Matteo Ferrando

1.3k total citations
27 papers, 893 citations indexed

About

Matteo Ferrando is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matteo Ferrando has authored 27 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 9 papers in Immunology and Allergy and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matteo Ferrando's work include Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (9 papers) and Eosinophilic Esophagitis (6 papers). Matteo Ferrando is often cited by papers focused on Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (9 papers) and Eosinophilic Esophagitis (6 papers). Matteo Ferrando collaborates with scholars based in Italy, United States and Brazil. Matteo Ferrando's co-authors include Giorgio Walter Canonica, Giovanni Passalacqua, Diego Bagnasco, Gilda Varricchi, Francesca Puggioni, Enrico Heffler, Francesca Racca, Luca Malvezzi, Fulvio Braido and Ilaria Baiardini and has published in prestigious journals such as Frontiers in Immunology, BioMed Research International and Allergy.

In The Last Decade

Matteo Ferrando

27 papers receiving 869 citations

Peers

Matteo Ferrando
K.‐U. Min South Korea
Claire A. Butler United Kingdom
Gerald B. Lee United States
Holgate United Kingdom
Matteo Ferrando
Citations per year, relative to Matteo Ferrando Matteo Ferrando (= 1×) peers Morgan Andersson

Countries citing papers authored by Matteo Ferrando

Since Specialization
Citations

This map shows the geographic impact of Matteo Ferrando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Ferrando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Ferrando more than expected).

Fields of papers citing papers by Matteo Ferrando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Ferrando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Ferrando. The network helps show where Matteo Ferrando may publish in the future.

Co-authorship network of co-authors of Matteo Ferrando

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Ferrando. A scholar is included among the top collaborators of Matteo Ferrando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Ferrando. Matteo Ferrando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santus, Pierachille, Dejan Radovanovic, Matteo Pecchiari, et al.. (2020). The Relevance of Targeting Treatment to Small Airways in Asthma and COPD. Respiratory Care. 65(9). 1392–1412. 36 indexed citations
2.
Santus, Pierachille, et al.. (2019). Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study. World Allergy Organization Journal. 12(4). 100030–100030. 13 indexed citations
3.
Nicolini, Antonello, Matteo Ferrando, Paolo Solidoro, et al.. (2019). Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome. Minerva Medica. 109(6 Suppl 1). 1–5. 13 indexed citations
4.
Ferrando, Matteo, Francesca Racca, Enrico Heffler, et al.. (2018). A critical appraisal on AIT in childhood asthma. Clinical and Molecular Allergy. 16(1). 6–6. 9 indexed citations
5.
Passalacqua, Giovanni, Diego Bagnasco, Matteo Ferrando, et al.. (2018). Current insights in allergen immunotherapy. Annals of Allergy Asthma & Immunology. 120(2). 152–154. 21 indexed citations
6.
Heffler, Enrico, Massimo Landi, Cristiano Caruso, et al.. (2018). Nasal cytology: Methodology with application to clinical practice and research. Clinical & Experimental Allergy. 48(9). 1092–1106. 53 indexed citations
7.
Heffler, Enrico, Matteo Ferrando, Francesca Puggioni, et al.. (2018). Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. The Journal of Allergy and Clinical Immunology In Practice. 6(3). 776–781. 142 indexed citations
8.
Ferrando, Matteo, Diego Bagnasco, Enrico Heffler, et al.. (2018). Personalizing the approach to asthma treatment. Expert Review of Precision Medicine and Drug Development. 3(5). 299–304. 5 indexed citations
9.
Bagnasco, Diego, Matteo Ferrando, Gilda Varricchi, et al.. (2017). Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma. Frontiers in Medicine. 4. 135–135. 68 indexed citations
10.
Varricchi, Gilda, Gianenrico Senna, Stefania Loffredo, et al.. (2017). Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?. Frontiers in Immunology. 8. 242–242. 39 indexed citations
11.
Bagnasco, Diego, Matteo Ferrando, Marco Caminati, et al.. (2017). Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations. Drug Safety. 40(7). 559–570. 19 indexed citations
12.
Ferrando, Matteo, Diego Bagnasco, Giovanni Passalacqua, et al.. (2017). New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases. Current Pharmaceutical Biotechnology. 18(5). 378–383. 1 indexed citations
13.
Bagnasco, Diego, Matteo Ferrando, Stefano Bernardi, Giovanni Passalacqua, & Giorgio Walter Canonica. (2016). The path to personalized medicine in asthma. Expert Review of Respiratory Medicine. 10(9). 957–965. 8 indexed citations
14.
Ferrando, Matteo, Diego Bagnasco, Giovanni Passalacqua, Gilda Varricchi, & Giorgio Walter Canonica. (2016). MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis. Expert Opinion on Biological Therapy. 16(11). 1435–1441. 1 indexed citations
15.
Bagnasco, Diego, Matteo Ferrando, Gilda Varricchi, Giovanni Passalacqua, & Giorgio Walter Canonica. (2016). A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. International Archives of Allergy and Immunology. 170(2). 122–131. 161 indexed citations
16.
Ferrando, Matteo, Diego Bagnasco, Gilda Varricchi, et al.. (2016). Personalized Medicine in Allergy. Allergy Asthma and Immunology Research. 9(1). 15–15. 41 indexed citations
17.
Ferrando, Matteo, Diego Bagnasco, Fulvio Braido, Gilda Varricchi, & Giorgio Walter Canonica. (2015). Biosimilars in allergic diseases. Current Opinion in Allergy and Clinical Immunology. 16(1). 68–73. 11 indexed citations
18.
Canonica, Giorgio Walter, et al.. (2015). Update on immunotherapy for the treatment of asthma. Current Opinion in Pulmonary Medicine. 22(1). 18–24. 13 indexed citations
19.
Braido, Fulvio, et al.. (2014). New Therapies for Allergic Rhinitis. Current Allergy and Asthma Reports. 14(4). 422–422. 14 indexed citations
20.
Ferrando, Matteo & Martin Henman. (1986). A SURVEY OF DRUG AND THERAPEUTICS COMMITTEES OPERATING IN IRELAND. Journal of Clinical Pharmacy and Therapeutics. 11(2). 131–140. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026